(Q50784030)

19 March 2018

title

Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. (English)

1 reference

19 March 2018

0 references

1

Hans D Ochs

1 reference

19 March 2018

author name string

Sudhir Gupta

2

1 reference

19 March 2018

Peter Kiessling

3

1 reference

19 March 2018

Uwe Nicolay

4

1 reference

19 March 2018

Melvin Berger

5

1 reference

19 March 2018

Subcutaneous IgG Study Group

6

1 reference

19 March 2018

publication date

1 May 2006

1 reference

19 March 2018

Journal of Clinical Immunology

published in

1 reference

19 March 2018

volume

26

1 reference

19 March 2018

issue

3

1 reference

19 March 2018

page(s)

265-273

1 reference

19 March 2018

Complications of intravenous immune globulin treatment in neurologic disease

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-006-9021-7

The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-006-9021-7

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-006-9021-7

Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases

21 January 2018

1 reference

12 December 2020

Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy

1 reference

12 December 2020

Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease

1 reference

12 December 2020

Subcutaneous immunoglobulin replacement in primary immunodeficiencies

1 reference

12 December 2020

1 reference

12 December 2020

Human intravenous immunoglobulin in primary and secondary antibody deficiencies

1 reference

12 December 2020

1 reference

12 December 2020

Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home.

1 reference

12 December 2020

Recommendations for off-label use of intravenously administered immunoglobulin preparations. University Hospital Consortium Expert Panel for Off-Label Use of Polyvalent Intravenously Administered Immunoglobulin Preparations

1 reference

12 December 2020

Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA

1 reference

12 December 2020

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy

1 reference

12 December 2020

Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies--a prospective, multi-national study

1 reference

12 December 2020

Immunoglobulin replacement treatment by rapid subcutaneous infusion

1 reference

12 December 2020

Octagam 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases

1 reference

12 December 2020

Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion

1 reference

12 December 2020

Relationship of the dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency

1 reference

12 December 2020

Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases

1 reference

12 December 2020

Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy

1 reference

12 December 2020

Corticosteroids for prevention of adverse reactions to intravenous immune serum globulin infusions in hypogammaglobulinemic patients

1 reference

12 December 2020

Immunoglobulin replacement therapy by slow subcutaneous infusion

1 reference

12 December 2020

Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs

1 reference

12 December 2020

Complications of intravenous gammaglobulin in neuromuscular and other diseases

1 reference

12 December 2020

10.1007/S10875-006-9021-7

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018